rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    STVN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Here’s What Drove Stevanato Group’s (STVN) Q3 Outperformance
      11h agoYahoo FinanceSTVN
      Stevanato Group at Jefferies conference: growth reset, long-term bets
      11h agoInvesting.comJEFSTVN
      Broader Biologics Growth Strengthens Stevanato’s (STVN) Long-Term Outlook
      Nov 10Yahoo FinanceSTVN
      Why Stevanato Group Bears Were Right Before The Drop
      Nov 4Yahoo FinanceSTVN
      William Blair downgrades Stevanato Group stock rating on 2027 outlook
      Nov 4Investing.comSTVN
      Stevanato Group (STVN) Faces Legal Investigation Over GLP 1 Disclosure
      Nov 4Yahoo FinanceSTVN
      Stevanato Group (STVN) Could Be 42% Undervalued Following Q3 Earnings

      Stevanato Group (STVN) just posted its third quarter 2026 earnings, reporting sales of €326.1 million and net income of €41.8 million. These results give investors fresh numbers to reassess the stock. Despite the solid Q3 report and the Aptar Pharma collaboration announced in late October, Stevanato Group’s recent trading tells a different story. The share price is down about 30% over the past month and the 1-year total shareholder return has declined about 43%, pointing to fading momentum as...

      Nov 4Yahoo FinanceSTVN
      Stevanato Group Q3 Earnings Call Highlights
      Nov 4Yahoo FinanceSTVN
      Stevanato Group S.p.A. Q3 2026 Earnings Call Summary
      Nov 4Yahoo FinanceSTVN
      Stevanato Group S.p.A. Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Stevanato Group S.p.A. (STVN)
      Nov 3MorningstarSTVN
      Stevanato Group SpA (STVN) (Q3 2026) Earnings Call Highlights: Revenue Climbs 8% as Non-GLP ...

      Stevanato Group SpA (STVN) delivered solid Q3 2026 organic growth and margin expansion while flagging a temporary, single-customer GLP-1 volume decline expected to moderate 2027 growth.

      Nov 3Yahoo FinanceSTVN
      Why is Stevanato stock plunging today?
      Nov 3Investing.comSTVN
      Earnings call transcript: Stevanato Group Q3 2026 beats revenue, shares sink 24%
      Nov 3Investing.comSTVN
      Stevanato Group Q3 2026 Earnings Call Transcript
      Nov 3BenzingaSTVN
      Stevanato Q3 Adjusted Earnings, Revenue Rise
      Nov 3Yahoo FinanceSTVN
      Stevanato Group SpA earnings matched, revenue topped estimates
      Nov 3Investing.comSTVN
      Stevanato Group (STVN) Surpasses Q3 Earnings and Revenue Estimates
      Nov 3Yahoo FinanceSTVN
      Stevanato: Q3 Earnings Snapshot
      Nov 3Yahoo FinanceSTVN
      Stevanato Group Delivers 8% Revenue Growth for the Third Quarter of Fiscal 2026
      Nov 3Yahoo FinanceSTVN
      Stevanato Group faces earnings test on GLP-1 packaging demand
      Nov 2Investing.comSTVN
      Stevanato Group S.p.A. (STVN) Rallies on 2Q26 Revenue Growth and EBITDA Margin Expansion
      Oct 28Yahoo FinanceSTVN
      Stevanato Group partners with Aptar for syringe testing
      Oct 27Investing.comATRSTVN
      Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection
      Oct 27Financial TimesSTVN
      Aptar Pharma and Stevanato Group Collaborate to Help Accelerate Pre-Filled Syringe System Selection
      Oct 27MorningstarSTVN
      Wall Street Analysts Are Bullish on Top Healthcare Picks

      Detailed price information for Unitedhealth Group (UNH-N) from The Globe and Mail including charting and trades.

      Oct 15The Globe and MailSTVN
      Deutsche Bank Initiates Stevanato Group at Hold, $22 Price Target
      Oct 7Yahoo FinanceSTVN
      Morgan Stanley Gives a Hold Rating to Stevanato Group (STVN)

      Detailed price information for Stevanato Group S.P.A. (STVN-N) from The Globe and Mail including charting and trades.

      Oct 6The Globe and MailSTVN
      Ensera launches alliance network with SHL Medical, Stevanato Group, Ypsomed, Argonaut and American Injectables
      Oct 1Yahoo FinanceSTVN
      UBS Remains a Hold on Stevanato Group (STVN)

      Detailed price information for Stevanato Group S.P.A. (STVN-N) from The Globe and Mail including charting and trades.

      Sep 10The Globe and MailSTVN
      UBS Adjusts Price Target on Stevanato Group to $23 From $28, Keeps Neutral Rating

      Stevanato Group SpA (STVN) has an average rating of overweight and mean price target of $25.16, acco

      Sep 9Yahoo FinanceSTVN
      Stevanato Group to Participate in Two Upcoming Investor Conferences

      PIOMBINO DESE, Italy, September 08, 2026--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in two upcoming investor conferences:

      Sep 8Yahoo FinanceSTVN
      Stevanato Group (STVN) Trades A Subsidiary For Margin Gains And Growth

      On August 4, Stevanato Group (NYSE:STVN) reported second-quarter revenue of €302.0 million, up 8% year over year, while also closing the sale of its California-based subsidiary, Balda C. Brewer Inc. The results paired steady growth in the company’s core drug containment and delivery business with a portfolio move that reshaped its bottom line for the […]

      Sep 4Yahoo FinanceSTVN
      Riverwater Sees a Market Overreaction in Stevanato Group (STVN) After Oral GLP-1 Launches

      Riverwater Partners, an investment management company, released its ‘Small Cap Strategy’ Q2 2026 investor letter. The letter can be downloaded here. The Small Cap Strategy underperformed the Russell 2000 in the second quarter as the benchmark experienced one of its strongest risk-on rallies in recent memory, although the strategy remained ahead year-to-date. The quarter was defined […]

      Sep 1Yahoo FinanceSTVN
      Stevanato Group: Alina Validates The Container-To-Device Flywheel (NYSE:STVN)

      Stevanato Group is transforming from a pharmaceutical glass supplier into an integrated drug containment and delivery platform. Learn why STVN stock is a buy.

      Aug 29Seeking AlphaSTVN
      Morgan Stanley Releases a Hold Rating on Stevanato Group (STVN)

      Detailed price information for Stevanato Group S.P.A. (STVN-N) from The Globe and Mail including charting and trades.

      Aug 25The Globe and MailSTVN

      This is the newest page. Registered accounts read further back.